|
Moringa in Diabetes |
02/11/2021 |
CIPPPB |
|
14F7 in chronic B-cell lymphoproliferative syndrome |
07/03/2018 |
CIM |
|
188Re-marked Ior C5 MAb in persistent or relapsing ovary epithelial cancer, phase I. |
2010-12-27 |
CIM |
|
ABDALA Clinical Study |
26/11/2020 |
CIGB |
|
ABDALA-Intervention |
27/03/2021 |
CIGB |
|
Abexol (suspension) versus Abexol (tablets) in patients with gastrointestinal symptoms |
22/05/2021 |
CPN |
|
Abexol and Atorvastatin in the non alcoholic steatohepatitis |
28/11/2016 |
CPN |
|
Abexol and Glucosamine/Chondroitin Sulphate in osteoarthritis: study of the 6 months. |
02/12/2016 |
CPN |
|
AMIGOS-2 study |
07/08/2018 |
CIGB |
|
An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NSCLC Participants Treated With Alectinib |
05/08/2021 |
ROCHE |
|
Anti SARS-CoV-2 gammaglobulin |
30/06/2021 |
AICA |
|
ATENEA-Co-300 study |
28/05/2020 |
CIGB |
|
Atorvastatin and dexamethasone in adult patients with chronic subdural hematoma; Phase I-II. |
28/03/2024 |
HUPMAD |
|
AVATAR-2020 |
01/03/2021 |
CIGB |
|
BACONAO Study |
12/11/2021 |
CIGB |
|
Bioequivalence of Abacavir |
27/09/2017 |
CIDEM |
|
Bioequivalence of Clopidogrel |
17/10/2017 |
CIDEM |
|
Bioequivalence of Digoxin |
28/11/2017 |
CIDEM |
|
Bioequivalence of Diltiazem retard |
28/11/2017 |
CIDEM |
|
Bioequivalence of Efavirenz |
22/12/2017 |
CIDEM |
